HCA Healthcare, Inc. (NYSE: HCA) Stock Competitors & Peer Comparison
See HCA's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HCA and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HCA | $504.89 | +2.00% | 105.5B | 17.44 | $28.96 | +0.61% |
| THC | $289.00 | +2.00% | 23B | 16.75 | $17.24 | N/A |
| EHC | $141.15 | +2.62% | 13.9B | 24.17 | $5.84 | +0.56% |
| FMS | $22.95 | -1.92% | 12.2B | 8.63 | $2.66 | +3.76% |
| DVA | $185.54 | -3.04% | 11.7B | 13.15 | $14.11 | N/A |
| ENSG | $182.10 | +0.56% | 10.6B | 26.37 | $6.90 | +0.14% |
| UHS | $197.16 | +0.85% | 10.2B | 8.75 | $22.54 | +0.41% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $48.77 | -1.67% | 7.7B | 25.78 | $1.89 | N/A |
| CHE | $538.06 | +1.90% | 7B | 24.91 | $21.61 | +0.46% |
Stock Comparison
Tenet Healthcare Corporation (NYSE: THC)
HCA vs THC Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, THC has a market cap of 23B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while THC trades at $289.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas THC's P/E ratio is 16.75. In terms of profitability, HCA's ROE is -1.00%, compared to THC's ROE of +0.61%. Regarding short-term risk, HCA is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for HCA.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
HCA vs EHC Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, EHC has a market cap of 13.9B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while EHC trades at $141.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas EHC's P/E ratio is 24.17. In terms of profitability, HCA's ROE is -1.00%, compared to EHC's ROE of +0.25%. Regarding short-term risk, HCA is less volatile compared to EHC. This indicates lower risk in terms of short-term price fluctuations for HCA.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
HCA vs FMS Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while FMS trades at $22.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas FMS's P/E ratio is 8.63. In terms of profitability, HCA's ROE is -1.00%, compared to FMS's ROE of +0.06%. Regarding short-term risk, HCA is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for HCA.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
HCA vs DVA Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, DVA has a market cap of 11.7B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while DVA trades at $185.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas DVA's P/E ratio is 13.15. In terms of profitability, HCA's ROE is -1.00%, compared to DVA's ROE of -1.33%. Regarding short-term risk, HCA is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for HCA.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
HCA vs ENSG Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while ENSG trades at $182.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas ENSG's P/E ratio is 26.37. In terms of profitability, HCA's ROE is -1.00%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, HCA is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for HCA.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
HCA vs UHS Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, UHS has a market cap of 10.2B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while UHS trades at $197.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas UHS's P/E ratio is 8.75. In terms of profitability, HCA's ROE is -1.00%, compared to UHS's ROE of +0.20%. Regarding short-term risk, HCA is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for HCA.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
HCA vs OSH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas OSH's P/E ratio is -17.65. In terms of profitability, HCA's ROE is -1.00%, compared to OSH's ROE of +4.64%. Regarding short-term risk, HCA is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for HCA.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
HCA vs PACS Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, PACS has a market cap of 7.7B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while PACS trades at $48.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas PACS's P/E ratio is 25.78. In terms of profitability, HCA's ROE is -1.00%, compared to PACS's ROE of +0.26%. Regarding short-term risk, HCA is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for HCA.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
HCA vs CHE Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, CHE has a market cap of 7B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while CHE trades at $538.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas CHE's P/E ratio is 24.91. In terms of profitability, HCA's ROE is -1.00%, compared to CHE's ROE of +0.32%. Regarding short-term risk, HCA is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for HCA.Check CHE's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
HCA vs LFST Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, LFST has a market cap of 5.6B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while LFST trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas LFST's P/E ratio is 109.93. In terms of profitability, HCA's ROE is -1.00%, compared to LFST's ROE of +0.05%. Regarding short-term risk, HCA is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for HCA.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
HCA vs CON Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, CON has a market cap of 5.4B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while CON trades at $42.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas CON's P/E ratio is 26.65. In terms of profitability, HCA's ROE is -1.00%, compared to CON's ROE of +0.48%. Regarding short-term risk, HCA is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for HCA.Check CON's competition here
LHC Group, Inc. (NASDAQ: LHCG)
HCA vs LHCG Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas LHCG's P/E ratio is 82.83. In terms of profitability, HCA's ROE is -1.00%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, HCA is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for HCA.Check LHCG's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
HCA vs HIMS Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, HIMS has a market cap of 5.2B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while HIMS trades at $22.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas HIMS's P/E ratio is -35.84. In terms of profitability, HCA's ROE is -1.00%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, HCA is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for HCA.Check HIMS's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
HCA vs OPCH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, OPCH has a market cap of 4.7B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while OPCH trades at $31.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas OPCH's P/E ratio is 18.42. In terms of profitability, HCA's ROE is -1.00%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, HCA is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for HCA.Check OPCH's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
HCA vs ACHC Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, ACHC has a market cap of 3.6B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while ACHC trades at $38.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas ACHC's P/E ratio is 19.40. In terms of profitability, HCA's ROE is -1.00%, compared to ACHC's ROE of -0.57%. Regarding short-term risk, HCA is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for HCA.Check ACHC's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
HCA vs SGRY Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, SGRY has a market cap of 3.4B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while SGRY trades at $26.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas SGRY's P/E ratio is 67.86. In terms of profitability, HCA's ROE is -1.00%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, HCA is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for HCA.Check SGRY's competition here
Amedisys, Inc. (NASDAQ: AMED)
HCA vs AMED Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AMED's P/E ratio is 39.30. In terms of profitability, HCA's ROE is -1.00%, compared to AMED's ROE of +0.04%. Regarding short-term risk, HCA is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for HCA.Check AMED's competition here
National HealthCare Corporation (AMEX: NHC)
HCA vs NHC Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, NHC has a market cap of 3.3B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while NHC trades at $209.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas NHC's P/E ratio is 26.65. In terms of profitability, HCA's ROE is -1.00%, compared to NHC's ROE of +0.10%. Regarding short-term risk, HCA is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for HCA.Check NHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
HCA vs GRDN Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, GRDN has a market cap of 3B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while GRDN trades at $47.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas GRDN's P/E ratio is 41.23. In terms of profitability, HCA's ROE is -1.00%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, HCA is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for HCA.Check GRDN's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
HCA vs AVAH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AVAH has a market cap of 2.9B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AVAH trades at $13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AVAH's P/E ratio is 19.41. In terms of profitability, HCA's ROE is -1.00%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, HCA is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AVAH's competition here
Ardent Health Inc. (NYSE: ARDT)
HCA vs ARDT Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, ARDT has a market cap of 2.5B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while ARDT trades at $17.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas ARDT's P/E ratio is 14.49. In terms of profitability, HCA's ROE is -1.00%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, HCA is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for HCA.Check ARDT's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
HCA vs MD Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, MD has a market cap of 2.5B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while MD trades at $31.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas MD's P/E ratio is 14.06. In terms of profitability, HCA's ROE is -1.00%, compared to MD's ROE of +0.17%. Regarding short-term risk, HCA is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for HCA.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
HCA vs ADUS Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, ADUS has a market cap of 2.3B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while ADUS trades at $122.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas ADUS's P/E ratio is 18.33. In terms of profitability, HCA's ROE is -1.00%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, HCA is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for HCA.Check ADUS's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
HCA vs BKD Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, BKD has a market cap of 2.2B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while BKD trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas BKD's P/E ratio is -16.11. In terms of profitability, HCA's ROE is -1.00%, compared to BKD's ROE of +0.89%. Regarding short-term risk, HCA is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for HCA.Check BKD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
HCA vs SEM Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas SEM's P/E ratio is 15.43. In terms of profitability, HCA's ROE is -1.00%, compared to SEM's ROE of +0.08%. Regarding short-term risk, HCA is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for HCA.Check SEM's competition here
Agilon Health, Inc. (NYSE: AGL)
HCA vs AGL Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AGL has a market cap of 1.9B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AGL trades at $114.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AGL's P/E ratio is -7.40. In terms of profitability, HCA's ROE is -1.00%, compared to AGL's ROE of -0.52%. Regarding short-term risk, HCA is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AGL's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
HCA vs AMEH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AMEH's P/E ratio is 39.25. In terms of profitability, HCA's ROE is -1.00%, compared to AMEH's ROE of +0.06%. Regarding short-term risk, HCA is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AMEH's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
HCA vs ASTH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, ASTH has a market cap of 1.7B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while ASTH trades at $33.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas ASTH's P/E ratio is 40.72. In terms of profitability, HCA's ROE is -1.00%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, HCA is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for HCA.Check ASTH's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
HCA vs HCSG Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, HCSG has a market cap of 1.7B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while HCSG trades at $24.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas HCSG's P/E ratio is 16.63. In terms of profitability, HCA's ROE is -1.00%, compared to HCSG's ROE of +0.20%. Regarding short-term risk, HCA is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for HCA.Check HCSG's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
HCA vs SNDA Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, SNDA has a market cap of 1.6B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while SNDA trades at $33.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas SNDA's P/E ratio is -5.36. In terms of profitability, HCA's ROE is -1.00%, compared to SNDA's ROE of -0.19%. Regarding short-term risk, HCA is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for HCA.Check SNDA's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
HCA vs USPH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, USPH has a market cap of 1.5B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while USPH trades at $99.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas USPH's P/E ratio is 39.32. In terms of profitability, HCA's ROE is -1.00%, compared to USPH's ROE of -0.00%. Regarding short-term risk, HCA is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for HCA.Check USPH's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
HCA vs AMN Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AMN has a market cap of 1.5B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AMN trades at $37.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AMN's P/E ratio is 12.53. In terms of profitability, HCA's ROE is -1.00%, compared to AMN's ROE of +0.15%. Regarding short-term risk, HCA is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AMN's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
HCA vs NUTX Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while NUTX trades at $194.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas NUTX's P/E ratio is 7.69. In terms of profitability, HCA's ROE is -1.00%, compared to NUTX's ROE of +0.44%. Regarding short-term risk, HCA is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for HCA.Check NUTX's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
HCA vs PNTG Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while PNTG trades at $36.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas PNTG's P/E ratio is 27.52. In terms of profitability, HCA's ROE is -1.00%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, HCA is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for HCA.Check PNTG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
HCA vs INNV Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, INNV has a market cap of 1.3B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while INNV trades at $9.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas INNV's P/E ratio is -461.00. In terms of profitability, HCA's ROE is -1.00%, compared to INNV's ROE of +0.04%. Regarding short-term risk, HCA is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for HCA.Check INNV's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
HCA vs BKDT Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas BKDT's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to BKDT's ROE of +0.89%. Regarding short-term risk, HCA is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for HCA.Check BKDT's competition here
Talkspace, Inc. (NASDAQ: TALK)
HCA vs TALK Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, TALK has a market cap of 870.6M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas TALK's P/E ratio is 774.34. In terms of profitability, HCA's ROE is -1.00%, compared to TALK's ROE of +0.00%. Regarding short-term risk, HCA is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for HCA.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
HCA vs EHAB Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas EHAB's P/E ratio is -197.14. In terms of profitability, HCA's ROE is -1.00%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, HCA is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for HCA.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
HCA vs GMRS Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, GMRS has a market cap of 609.4M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while GMRS trades at $11.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas GMRS's P/E ratio is -5.56. In terms of profitability, HCA's ROE is -1.00%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, HCA is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for HCA.Check GMRS's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
HCA vs SRTA Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, SRTA has a market cap of 534.8M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while SRTA trades at $6.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas SRTA's P/E ratio is -28.50. In terms of profitability, HCA's ROE is -1.00%, compared to SRTA's ROE of -0.09%. Regarding short-term risk, HCA is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for HCA.Check SRTA's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
HCA vs TOI Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas TOI's P/E ratio is -14.25. In terms of profitability, HCA's ROE is -1.00%, compared to TOI's ROE of +1.51%. Regarding short-term risk, HCA is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for HCA.Check TOI's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
HCA vs MCTA Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas MCTA's P/E ratio is 419.36. In terms of profitability, HCA's ROE is -1.00%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, HCA is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for HCA.Check MCTA's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
HCA vs STLN Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, STLN has a market cap of 399.4M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while STLN trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas STLN's P/E ratio is -13.09. In terms of profitability, HCA's ROE is -1.00%, compared to STLN's ROE of +1.51%. Regarding short-term risk, HCA is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for HCA.Check STLN's competition here
Auna S.A. (NYSE: AUNA)
HCA vs AUNA Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AUNA has a market cap of 347.1M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AUNA trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AUNA's P/E ratio is 4.23. In terms of profitability, HCA's ROE is -1.00%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, HCA is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
HCA vs VMD Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, VMD has a market cap of 341.7M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while VMD trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas VMD's P/E ratio is 24.92. In terms of profitability, HCA's ROE is -1.00%, compared to VMD's ROE of +0.11%. Regarding short-term risk, HCA is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for HCA.Check VMD's competition here
Community Health Systems, Inc. (NYSE: CYH)
HCA vs CYH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, CYH has a market cap of 318.7M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while CYH trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas CYH's P/E ratio is 3.10. In terms of profitability, HCA's ROE is -1.00%, compared to CYH's ROE of -0.03%. Regarding short-term risk, HCA is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for HCA.Check CYH's competition here
Capital Senior Living Corporation (NYSE: CSU)
HCA vs CSU Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas CSU's P/E ratio is 0.67. In terms of profitability, HCA's ROE is -1.00%, compared to CSU's ROE of -0.23%. Regarding short-term risk, HCA is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for HCA.Check CSU's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
HCA vs PARK Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, PARK has a market cap of 99.9M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while PARK trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas PARK's P/E ratio is 28.38. In terms of profitability, HCA's ROE is -1.00%, compared to PARK's ROE of -0.18%. Regarding short-term risk, HCA is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for HCA.Check PARK's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
HCA vs FVE Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas FVE's P/E ratio is -5.64. In terms of profitability, HCA's ROE is -1.00%, compared to FVE's ROE of -0.15%. Regarding short-term risk, HCA is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for HCA.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
HCA vs KDLYW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas KDLYW's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, HCA is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for HCA.Check KDLYW's competition here
The Joint Corp. (NASDAQ: JYNT)
HCA vs JYNT Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, JYNT has a market cap of 94.1M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while JYNT trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas JYNT's P/E ratio is 44.33. In terms of profitability, HCA's ROE is -1.00%, compared to JYNT's ROE of +0.30%. Regarding short-term risk, HCA is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for HCA.Check JYNT's competition here
biote Corp. (NASDAQ: BTMD)
HCA vs BTMD Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, BTMD has a market cap of 49.2M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while BTMD trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas BTMD's P/E ratio is 10.14. In terms of profitability, HCA's ROE is -1.00%, compared to BTMD's ROE of +0.03%. Regarding short-term risk, HCA is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for HCA.Check BTMD's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
HCA vs AIRS Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AIRS has a market cap of 48.8M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AIRS trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AIRS's P/E ratio is -22.54. In terms of profitability, HCA's ROE is -1.00%, compared to AIRS's ROE of -0.09%. Regarding short-term risk, HCA is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AIRS's competition here
AlerisLife Inc. (NASDAQ: ALR)
HCA vs ALR Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas ALR's P/E ratio is -1.11. In terms of profitability, HCA's ROE is -1.00%, compared to ALR's ROE of -0.15%. Regarding short-term risk, HCA is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for HCA.Check ALR's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
HCA vs EUDA Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, EUDA has a market cap of 42M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while EUDA trades at $14.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas EUDA's P/E ratio is -12.06. In terms of profitability, HCA's ROE is -1.00%, compared to EUDA's ROE of -5.06%. Regarding short-term risk, HCA is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for HCA.Check EUDA's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
HCA vs CCEL Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, CCEL has a market cap of 40.2M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while CCEL trades at $4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas CCEL's P/E ratio is -21.70. In terms of profitability, HCA's ROE is -1.00%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, HCA is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for HCA.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
HCA vs IMAC Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas IMAC's P/E ratio is -2.27. In terms of profitability, HCA's ROE is -1.00%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, HCA is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for HCA.Check IMAC's competition here
DocGo Inc. (NASDAQ: DCGO)
HCA vs DCGO Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, DCGO has a market cap of 25.4M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while DCGO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas DCGO's P/E ratio is -0.14. In terms of profitability, HCA's ROE is -1.00%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, HCA is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for HCA.Check DCGO's competition here
Cano Health, Inc. (NYSE: CANO-WT)
HCA vs CANO-WT Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, HCA is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for HCA.Check CANO-WT's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
HCA vs PIIIW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, PIIIW has a market cap of 17.7M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas PIIIW's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, HCA is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for HCA.Check PIIIW's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
HCA vs AIH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AIH's P/E ratio is -2.78. In terms of profitability, HCA's ROE is -1.00%, compared to AIH's ROE of +1.16%. Regarding short-term risk, HCA is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
HCA vs PIII Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, PIII has a market cap of 13.9M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while PIII trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas PIII's P/E ratio is -0.13. In terms of profitability, HCA's ROE is -1.00%, compared to PIII's ROE of +1.61%. Regarding short-term risk, HCA is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for HCA.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO)
HCA vs CANO Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas CANO's P/E ratio is -0.01. In terms of profitability, HCA's ROE is -1.00%, compared to CANO's ROE of -1.49%. Regarding short-term risk, HCA is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for HCA.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
HCA vs FPCG Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas FPCG's P/E ratio is 0.09. In terms of profitability, HCA's ROE is -1.00%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, HCA is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for HCA.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
HCA vs FTRP Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas FTRP's P/E ratio is -1.22. In terms of profitability, HCA's ROE is -1.00%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, HCA is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for HCA.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
HCA vs BMGL Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, BMGL has a market cap of 8.5M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while BMGL trades at $5.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas BMGL's P/E ratio is -1.08. In terms of profitability, HCA's ROE is -1.00%, compared to BMGL's ROE of -0.11%. Regarding short-term risk, HCA is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for HCA.Check BMGL's competition here
American Shared Hospital Services (AMEX: AMS)
HCA vs AMS Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AMS has a market cap of 8M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AMS trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AMS's P/E ratio is -4.79. In terms of profitability, HCA's ROE is -1.00%, compared to AMS's ROE of -0.07%. Regarding short-term risk, HCA is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AMS's competition here
ModivCare Inc. (NASDAQ: MODV)
HCA vs MODV Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas MODV's P/E ratio is -0.06. In terms of profitability, HCA's ROE is -1.00%, compared to MODV's ROE of +0.88%. Regarding short-term risk, HCA is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for HCA.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
HCA vs GBNH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas GBNH's P/E ratio is -0.06. In terms of profitability, HCA's ROE is -1.00%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, HCA is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for HCA.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
HCA vs RHE Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas RHE's P/E ratio is -1.79. In terms of profitability, HCA's ROE is -1.00%, compared to RHE's ROE of +1.09%. Regarding short-term risk, HCA is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for HCA.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
HCA vs RHE-PA Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, HCA's ROE is -1.00%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, HCA is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for HCA.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
HCA vs TOIIW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, HCA's ROE is -1.00%, compared to TOIIW's ROE of +1.51%. Regarding short-term risk, HCA is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for HCA.Check TOIIW's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
HCA vs AIDX Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AIDX has a market cap of 2.7M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AIDX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AIDX's P/E ratio is -0.28. In terms of profitability, HCA's ROE is -1.00%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, HCA is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
HCA vs IMACW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas IMACW's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to IMACW's ROE of +0.46%. Regarding short-term risk, HCA is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for HCA.Check IMACW's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
HCA vs STLNW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, STLNW has a market cap of 1.2M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while STLNW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas STLNW's P/E ratio is -0.04. In terms of profitability, HCA's ROE is -1.00%, compared to STLNW's ROE of +1.51%. Regarding short-term risk, HCA is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for HCA.Check STLNW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
HCA vs EDVA Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, EDVA has a market cap of 1.2M. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while EDVA trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas EDVA's P/E ratio is -0.01. In terms of profitability, HCA's ROE is -1.00%, compared to EDVA's ROE of N/A. Regarding short-term risk, HCA is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for HCA.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
HCA vs EUDAW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, EUDAW has a market cap of 616.3K. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas EUDAW's P/E ratio is -0.01. In terms of profitability, HCA's ROE is -1.00%, compared to EUDAW's ROE of -5.06%. Regarding short-term risk, HCA is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for HCA.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
HCA vs CCM Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, CCM has a market cap of 539.8K. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while CCM trades at $3.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas CCM's P/E ratio is -1.25. In terms of profitability, HCA's ROE is -1.00%, compared to CCM's ROE of +0.05%. Regarding short-term risk, HCA is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for HCA.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
HCA vs NIVF Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, NIVF has a market cap of 482.8K. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while NIVF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas NIVF's P/E ratio is 0.19. In terms of profitability, HCA's ROE is -1.00%, compared to NIVF's ROE of -292.08%. Regarding short-term risk, HCA is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for HCA.Check NIVF's competition here
Talkspace, Inc. (NASDAQ: TALKW)
HCA vs TALKW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas TALKW's P/E ratio is 0.00. In terms of profitability, HCA's ROE is -1.00%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, HCA is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for HCA.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
HCA vs MNDR Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, MNDR has a market cap of 24.3K. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while MNDR trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas MNDR's P/E ratio is -0.07. In terms of profitability, HCA's ROE is -1.00%, compared to MNDR's ROE of -0.31%. Regarding short-term risk, HCA is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for HCA.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
HCA vs NIVFW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, NIVFW has a market cap of 20.5K. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while NIVFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas NIVFW's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to NIVFW's ROE of -292.08%. Regarding short-term risk, HCA is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for HCA.Check NIVFW's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
HCA vs TNONW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, TNONW has a market cap of 5.2K. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while TNONW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas TNONW's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to TNONW's ROE of N/A. Regarding short-term risk, HCA is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for HCA.Check TNONW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
HCA vs KND Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, KND has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas KND's P/E ratio is -1.14. In terms of profitability, HCA's ROE is -1.00%, compared to KND's ROE of -0.53%. Regarding short-term risk, HCA is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for HCA.Check KND's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
HCA vs TLMDW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas TLMDW's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, HCA is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for HCA.Check TLMDW's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
HCA vs SLHG Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas SLHG's P/E ratio is -1.48. In terms of profitability, HCA's ROE is -1.00%, compared to SLHG's ROE of N/A. Regarding short-term risk, HCA is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for HCA.Check SLHG's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
HCA vs SLHGP Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, HCA's ROE is -1.00%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, HCA is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for HCA.Check SLHGP's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
HCA vs DVCR Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas DVCR's P/E ratio is 28.34. In terms of profitability, HCA's ROE is -1.00%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, HCA is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for HCA.Check DVCR's competition here
DocGo Inc. (NASDAQ: DCGOW)
HCA vs DCGOW Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas DCGOW's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, HCA is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for HCA.Check DCGOW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
HCA vs TVTY Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas TVTY's P/E ratio is 19.06. In terms of profitability, HCA's ROE is -1.00%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, HCA is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for HCA.Check TVTY's competition here
New Frontier Health Corporation (NYSE: NFH)
HCA vs NFH Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, NFH has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas NFH's P/E ratio is -19.75. In terms of profitability, HCA's ROE is -1.00%, compared to NFH's ROE of -0.06%. Regarding short-term risk, HCA is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for HCA.Check NFH's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
HCA vs ATIP-WT Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, HCA is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for HCA.Check ATIP-WT's competition here
Hanger, Inc. (NYSE: HNGR)
HCA vs HNGR Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas HNGR's P/E ratio is 19.71. In terms of profitability, HCA's ROE is -1.00%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, HCA is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for HCA.Check HNGR's competition here
Almost Family Inc. (NASDAQ: AFAM)
HCA vs AFAM Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas AFAM's P/E ratio is N/A. In terms of profitability, HCA's ROE is -1.00%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, HCA is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for HCA.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
HCA vs TLMD Comparison November 2026
HCA Healthcare, Inc. (NYSE: HCA) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HCA stands at 105.5B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, HCA is priced at $504.89 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HCA currently has a P/E ratio of 17.44, whereas TLMD's P/E ratio is -1.60. In terms of profitability, HCA's ROE is -1.00%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, HCA is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for HCA.Check TLMD's competition here